CJLM Meijer

3.0k total citations · 2 hit papers
16 papers, 2.3k citations indexed

About

CJLM Meijer is a scholar working on Epidemiology, Surgery and Immunology. According to data from OpenAlex, CJLM Meijer has authored 16 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 4 papers in Surgery and 4 papers in Immunology. Recurrent topics in CJLM Meijer's work include Cervical Cancer and HPV Research (11 papers), Immunotherapy and Immune Responses (3 papers) and Reproductive tract infections research (3 papers). CJLM Meijer is often cited by papers focused on Cervical Cancer and HPV Research (11 papers), Immunotherapy and Immune Responses (3 papers) and Reproductive tract infections research (3 papers). CJLM Meijer collaborates with scholars based in Netherlands, Greece and France. CJLM Meijer's co-authors include PJF Snijders, Marjolein van Ballegooijen, Johannes Berkhof, Folkert J. van Kemenade, RHM Verheijen, Catterina Ferreccio, Elena Matos, Guglielmo Ronco, H. R. Shin and Rolando Herrero and has published in prestigious journals such as The Lancet, British Journal of Cancer and The Journal of Pathology.

In The Last Decade

CJLM Meijer

16 papers receiving 2.2k citations

Hit Papers

Worldwide distribution of... 2005 2026 2012 2019 2005 2007 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis
    2005 828 citations Silvano Gallus, Rolando Herrero et al. The Lancet profile →
  2. Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial
    2007 483 citations Johannes Berkhof, Lawrence Rozendaal et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
CJLM Meijer Netherlands 15 1.8k 876 488 352 325 16 2.3k
Linda Ho United Kingdom 25 2.5k 1.3× 1.0k 1.2× 538 1.1× 651 1.8× 435 1.3× 47 2.8k
Mark H. Stoler United States 25 1.9k 1.0× 1.5k 1.7× 977 2.0× 380 1.1× 176 0.5× 47 3.1k
Francesca Carozzi Italy 22 1.9k 1.0× 941 1.1× 754 1.5× 528 1.5× 478 1.5× 66 2.9k
Jussi Tarkkanen Finland 28 821 0.4× 674 0.8× 770 1.6× 291 0.8× 144 0.4× 98 2.2k
Ciarán Woodman United Kingdom 23 1.8k 1.0× 816 0.9× 700 1.4× 660 1.9× 258 0.8× 46 2.7k
B Hagmar Sweden 36 1.9k 1.0× 931 1.1× 825 1.7× 907 2.6× 295 0.9× 115 3.5k
Walter Ryd Sweden 27 2.0k 1.1× 1.2k 1.3× 892 1.8× 397 1.1× 368 1.1× 68 3.3k
J. M. M. Walboomers Netherlands 25 1.1k 0.6× 413 0.5× 681 1.4× 482 1.4× 171 0.5× 33 2.0k
Jesper Bonde Denmark 30 2.0k 1.1× 699 0.8× 617 1.3× 732 2.1× 400 1.2× 111 2.5k
Annarosa Del Mistro Italy 33 2.9k 1.6× 1.5k 1.7× 1.1k 2.3× 618 1.8× 449 1.4× 106 4.2k

Countries citing papers authored by CJLM Meijer

Since Specialization
Citations

This map shows the geographic impact of CJLM Meijer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by CJLM Meijer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites CJLM Meijer more than expected).

Fields of papers citing papers by CJLM Meijer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by CJLM Meijer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by CJLM Meijer. The network helps show where CJLM Meijer may publish in the future.

Co-authorship network of co-authors of CJLM Meijer

This figure shows the co-authorship network connecting the top 25 collaborators of CJLM Meijer. A scholar is included among the top collaborators of CJLM Meijer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with CJLM Meijer. CJLM Meijer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Steenbergen, Renske D.M., et al.. (2020). The use of host cell DNA methylation analysis in the detection and management of women with advanced cervical intraepithelial neoplasia: a review. BJOG An International Journal of Obstetrics & Gynaecology. 128(3). 504–514. 69 indexed citations
2.
Zaal, Afra, Johannes Berkhof, Mariëlle Kocken, et al.. (2012). Agreement between colposcopic impression and histological diagnosis among human papillomavirus type 16‐positive women: a clinical trial using dynamic spectral imaging colposcopy. BJOG An International Journal of Obstetrics & Gynaecology. 119(5). 537–544. 42 indexed citations
3.
Bontkes, Hetty J., et al.. (2012). Effector memory T‐cell frequencies in relation to tumour stage, location and HPV status in HNSCC patients. Oral Diseases. 19(6). 577–584. 32 indexed citations
4.
Zaal, Afra, Mariëlle Kocken, Johannes Berkhof, et al.. (2010). Dynamic spectral imaging colposcopy: higher sensitivity for detection of premalignant cervical lesions. BJOG An International Journal of Obstetrics & Gynaecology. 118(3). 309–318. 63 indexed citations
5.
Snijders, PJF, et al.. (2008). Vaccination against HPV: indications for women and the impact on the cervical screening programme. BJOG An International Journal of Obstetrics & Gynaecology. 115(8). 938–946. 16 indexed citations
6.
Berkhof, Johannes, Lawrence Rozendaal, Folkert J. van Kemenade, et al.. (2007). Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial. The Lancet. 370(9601). 1764–1772. 483 indexed citations breakdown →
7.
8.
Meijer, CJLM, et al.. (2006). Churn Prediction in the Mobile Telecommunications Industry. 7 indexed citations
9.
Gallus, Silvano, Rolando Herrero, Núbia Muñóz, et al.. (2005). Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. The Lancet. 366(9490). 991–998. 828 indexed citations breakdown →
10.
Frisch, Morten, Bengt Glimelius, Jan Wohlfahrt, et al.. (1998). Benign anal lesions, inflammatory bowel disease and risk for high-risk human papillomavirus-positive and -negative anal carcinoma. British Journal of Cancer. 78(11). 1534–1538. 33 indexed citations
11.
12.
Ballegooijen, Marjolein van, et al.. (1997). Present evidence on the value of HPV testing for cervical cancer screening: a model-based exploration of the (cost-)effectiveness. British Journal of Cancer. 76(5). 651–657. 65 indexed citations
13.
Snijders, PJF, et al.. (1995). Processing of long-stored archival cervical smears for human papillomavirus detection by the polymerase chain reaction. British Journal of Cancer. 72(2). 412–417. 120 indexed citations
14.
Eluf‐Neto, José, et al.. (1994). Human papillomavirus and invasive cervical cancer in Brazil. British Journal of Cancer. 69(1). 114–119. 209 indexed citations
15.
Meijer, CJLM, et al.. (1993). Analysis of MHC class I and II expression in relation to presence of HPV genotypes in premalignant and malignant cervical lesions. British Journal of Cancer. 67(6). 1372–1380. 105 indexed citations
16.
Gerretsen, Martijn, et al.. (1992). Radioimmunotherapy of human head and neck squamous cell carcinoma xenografts with 131I-labelled monoclonal antibody E48 IgG. British Journal of Cancer. 66(3). 496–502. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Linda Ho Breakdown of academic impact, for papers by Mark H. Stoler Breakdown of academic impact, for papers by Francesca Carozzi Breakdown of academic impact, for papers by Jussi Tarkkanen Breakdown of academic impact, for papers by Ciarán Woodman Breakdown of academic impact, for papers by B Hagmar Breakdown of academic impact, for papers by Walter Ryd Breakdown of academic impact, for papers by J. M. M. Walboomers Breakdown of academic impact, for papers by Jesper Bonde Breakdown of academic impact, for papers by Annarosa Del Mistro
Rankless by CCL
2026